{
    "id": "dbpedia_7697_3",
    "rank": 64,
    "data": {
        "url": "https://www.pharmacist.com/Education/Certificate-Training-Programs/Immunization",
        "read_more_link": "",
        "language": "en",
        "title": "Immunization",
        "top_image": "https://pharmacist.com/DNNGlobalStorageRedirector.ashx?egsfid=wUi9Lb0AEbc%3d",
        "meta_img": "https://pharmacist.com/DNNGlobalStorageRedirector.ashx?egsfid=wUi9Lb0AEbc%3d",
        "images": [
            "https://www.pharmacist.com/DNNGlobalStorageRedirector.ashx?egsfid=FuR0vQtFEJo%3d",
            "https://www.pharmacist.com/Portals/_default/skins/aphatheme/images/search.svg",
            "https://www.pharmacist.com/DNNGlobalStorageRedirector.ashx?egsfid=8fyJaoiw9wE%3d",
            "https://www.pharmacist.com/Portals/_default/skins/aphatheme/images/Apha_logo_ white.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "pharmacists",
            "pharmacy",
            "pharmacy association",
            "pharmacy education"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "APhA is the leading advocate for the pharmacy profession and a driving force in creating opportunities for pharmacists to play a key role in integrated patient care, and ensuring the profession is recognized as essential in optimal medication use.",
        "meta_lang": "en",
        "meta_favicon": "/Portals/0/favicon.ico?ver=JAEABFroiuXwSqFx2oLTCg%3d%3d",
        "meta_site_name": "",
        "canonical_link": "https://www.pharmacist.com/Education/Certificate-Training-Programs/Immunization/",
        "text": "Module 01 - Immunizations and the Role of Pharmacists\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the impact that vaccines have had on public health\n\nExplain how pharmacists and student pharmacists can help to improve vaccination rates\n\nIdentify opportunities for pharmacists and student pharmacists to be immunization advocates\n\nModule 02 - Introduction to Immunology\n\nAt the completion of this activity, participants will be able to:\n\nIdentify the differences between active and passive immunity\n\nExplain how vaccines elicit an immune response via the adaptive immune process\n\nDiscuss the rationale for timing of vaccine administration and intervals between doses, including spacing between other vaccines and antibodies\n\nDescribe principles of herd immunity\n\nModule 03 - Vaccine Types and Technologies\n\nAt the completion of this activity, participants will be able to:\n\nIdentify vaccines that are live and inactivated\n\nDescribe the characteristics and distinctions between live and inactivated vaccines\n\nDiscuss the rationale for timing of vaccine administration and intervals between dosing\n\nModule 04 - Immunizations and the Pharmacists’ Patient Care Process\n\nAt the completion of this activity, participants will be able to:\n\nApply the Pharmacists’ Patient Care Process to immunization services\n\nIdentify how and when to assess patients for vaccination needs\n\nDetermine appropriate screening questions to identify precautions and contraindications to vaccinations\n\nModule 05 - Immunization Recommendations and Schedules\n\nAt the completion of this activity, participants will be able to:\n\nDifferentiate between immunization recommendations, vaccine product approvals, and emergency use authorizations\n\nLocate and apply the Advisory Committee on Immunization Practices (ACIP) recommendations\n\nExplain how to read and interpret the CDC’s immunization schedules for children, adolescents, and adults\n\nModule 06 - Influenza\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the transmission and clinical features of influenza\n\nCompare and contrast symptoms of the common cold and influenza\n\nIdentify age-appropriate influenza vaccination options for a patient\n\nDescribe efficacy and safety information related to influenza vaccinations\n\nModule 07 - Pneumococcal\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the causes, clinical features, and potential complications of pneumococcal disease that can be prevented with vaccination\n\nIdentify target groups who should receive the pneumococcal vaccination based on risk factors and on recommendations by the Advisory Committee on Immunization (ACIP)\n\nList the pneumococcal vaccines approved for use in the U.S. and how they differ\n\nModule 08 - Meningococcal\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the causes, clinical features, and potential complications of meningococcal disease that can be prevented with vaccination\n\nIdentify target groups who should receive meningococcal vaccination based on risk factors, including outbreaks, and ACIP recommendations\n\nList the meningococcal vaccines approved for use in the U.S. and the ways they differ\n\nIdentify the recommended groups and discussion points to include during shared clinical decision-making for meningococcal B vaccines\n\nModule 09 - Human Papillomavirus\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the clinical features and potential complications of human papillomavirus disease\n\nIdentify target groups who should receive the human papillomavirus vaccine based on ACIP recommendations\n\nDevelop patient education strategies for potential human papillomavirus vaccine recipients\n\nModule 10 - Tetanus, Diphtheria and Pertussis\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the clinical features and potential complications of tetanus, diphtheria, and pertussis infections\n\nCompare and contrast vaccines to prevent tetanus, diphtheria, and pertussis\n\nIdentify target groups who should receive the vaccines containing tetanus, diphtheria, and pertussis based on ACIP recommendations\n\nModule 11 - Varicella and Zoster\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the clinical features and potential complications of disease due to varicella zoster virus\n\nIdentify target groups who should receive the varicella and zoster vaccines based on ACIP recommendations\n\nList the varicella and zoster vaccines approved for use in the U.S. and the ways they differ\n\nModule 12 - Hepatitis A & B\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the causes of, clinical features, and potential complications of hepatitis A and hepatitis B\n\nList the characteristics of the hepatitis A and hepatitis B vaccines, including the combination vaccine\n\nIdentify target groups who should receive the hepatitis A and hepatitis B vaccines based on risk factors and ACIP recommendations\n\nDescribe the causes of recent hepatitis A and hepatitis B outbreaks and the way such outbreaks can be prevented and managed\n\nExplain the pre- and post-testing recommendations for the hepatitis B vaccine\n\nModule 13 - Measles, Mumps and Rubella\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the causes of, clinical features, and potential complications of measles, mumps, and rubella\n\nList the characteristics and contraindications of the measles, mumps, and rubella (MMR) vaccine\n\nIdentify target groups who should receive the MMR vaccine based on risk factors and ACIP recommendations\n\nDiscuss the impact of recent measles and mumps outbreaks\n\nModule 14 - Additional Pediatric Vaccine-Preventable Diseases (Polio, Hib, and Rotavirus)\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the clinical features and potential complications of rotavirus, Haemophilus influenzae (Hib), and polio infections\n\nIdentify recommended groups who should receive the rotavirus, Hib, and polio vaccines based on ACIP recommendations\n\nIncorporate combination vaccines into recommended vaccination plans for pediatric patients\n\nModule 15 - COVID-19\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the causes of, clinical features, and potential complications of COVID-19\n\nRecognize groups at high risk for COVID-19 disease or exposure\n\nList the COVID-19 vaccines available in the U.S.\n\nDifferentiate a third dose from a booster dose\n\nDescribe the safety concerns and adverse reactions with the vaccines, including when coadministered with other vaccines\n\nList the documentation required following COVID-19 vaccine administration\n\nModule 16 - Educating Patients About Vaccines\n\nAt the completion of this activity, participants will be able to:\n\nDefine vaccine hesitancy and strategies to build patient confidence in vaccines\n\nAddress vaccine misinformation and safety concerns\n\nUse a shared decision-making approach when recommending vaccines to patients\n\nCommunicate risks and benefits of vaccines\n\nProvide postvaccination counseling\n\nModule 17 - Vaccine Storage and Handling\n\nAt the completion of this activity, participants will be able to:\n\nExplain the importance of maintaining the cold chain for vaccines\n\nDescribe recommendations from the CDC regarding proper storage and handling of vaccines\n\nModule 18 - Vaccine Administration Overview\n\nAt the completion of this activity, participants will be able to:\n\nDescribe how to prepare vaccines for administration\n\nExplain how to administer intramuscular and subcutaneous vaccines to adults and children\n\nList steps for preventing errors with vaccine administration\n\nModule 19 - Managing Vaccine Reactions\n\nAt the completion of this activity, participants will be able to:\n\nCompare and contrast local, systemic, and allergic reactions to a vaccine\n\nDescribe the process to appropriately manage vaccine reactions\n\nRecognize and treat anaphylaxis owing to a vaccine\n\nModule 20 - Standing Orders and Protocols\n\nAt the completion of this activity, participants will be able to:\n\nExplain the purpose of standing orders and protocols\n\nDescribe information that should be included in standing orders and protocols for immunization services.\n\nList resources for more information about standing orders and protocols for immunization services\n\nModule 21 - Documentation and Liability\n\nAt the completion of this activity, participants will be able to:\n\nDescribe information that should be included in documentation for vaccinations\n\nDiscuss the use of immunization information systems\n\nDescribe national reporting systems for adverse events and errors associated with vaccines\n\nExplain liability risks and legal protections for authorized immunizers\n\nModule 22 - Administrative and Operational Issues\n\nAt the completion of this activity, participants will be able to:\n\nDescribe the components of the Occupational Safety and Health Administration (OSHA) Bloodborne Pathogens Standard\n\nExplain how to implement reminder and recall systems for multidose vaccine series\n\nModule 23 - Payments for Immunization Services\n\nAt the completion of this activity, participants will be able to:\n\nList opportunities to obtain compensation and reimbursement for vaccination services\n\nIdentify codes that are used when billing third-party payers for vaccinations\n\nDescribe the process and rules around billing for immunizations\n\nModule - Vaccine Hesitancy and Motivational Interviewing\n\nAt the completion of this activity, participants will be able to:\n\nDescribe vaccine hesitancy\n\nDiscuss the role of social determinants of health in vaccine hesitancy\n\nList steps of the transtheoretical model of health behavior change\n\nDescribe key principles of motivational interviewing\n\nExplain how to apply motivational interviewing skills and strategies\n\nModule - Pharmacy Workflow for Immunization Services\n\nAt the completion of this activity, participants will be able to:\n\nExplain how the pharmacy practice setting affects workflow models for immunization services\n\nList factors that affect scheduling for vaccine services\n\nDescribe roles for support staff in the delivery of pharmacy-based immunization services\n\nModule - Mass Vaccination Clinics\n\nAt the completion of this activity, participants will be able to:\n\nList situations in which a mass vaccination clinic would be appropriate\n\nDescribe considerations for planning a mass vaccination clinic\n\nIdentify best practices for a mass vaccination clinic\n\nModule - Marketing an Immunization Program\n\nAt the completion of this activity, participants will be able to:\n\nDescribe print and nonprint strategies that can be used to market vaccination services\n\nList examples of free print and nonprint materials that can be used to market vaccination services\n\nExplain how pharmacists can develop relationships in their community that support their vaccination services\n\nModule - Working with Pharmacy Technicians\n\nAt the completion of this activity, participants will be able to:\n\nExplain roles for pharmacy technicians in supporting pharmacy-based immunization services\n\nIdentify immunization-related roles that should be performed by only pharmacists\n\nList activities that pharmacy technicians can perform to streamline the workflow for vaccination and pharmacy operations\n\nModule - Volunteer Opportunities and International Vaccine Programs\n\nAt the completion of this activity, participants will be able to:\n\nDiscuss volunteer roles for pharmacists in public health immunization programs\n\nDescribe opportunities for pharmacists to become involved with international vaccination programs and global public health promotion\n\nDescribe liability and scope-of-practice considerations for volunteering pharmacists\n\nThe American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. APhA's Pharmacy-Based Immunization Delivery certificate training program is approved for a total of 20.0 contact hours of continuing pharmacy education (CPE) credit (2.0 CEUs). The ACPE Universal Activity Numbers (UAN) for this activity are listed below.\n\nSuccessful completion of the home-study component involves completing each activity and passing the home-study assessments with a grade of 70% or higher and will result in 12 contact hours of CPE credit (1.2 CEUs).\n\nACPE UAN: 0202-0000-23-154-H06-P\n\n>Successful completion of the live session component involves attending the full live seminar, successfully completing & uploading the injection technique assessment, completing the online assessment with a grade of 70% or higher and evaluations. Successful completion of this component will result in 8 contact hours of CPE credit (0.8 CEU).\n\nACPE UAN: 0202-0000-23-155-L06-P / 0202-9999-23-155-L06-P\n\nTo obtain 20.0 contact hours of CPE credit (2.0 CEUs) for APhA's Pharmacy-Based Immunization Delivery certificate training program, the learner must have an updated APhA My Account, CPE & License Information BEFORE completing the home-study course, and completing the live components listed above. Participants will need to have a valid APhA (pharmacist.com) username and password, as well as a CPE Monitor account to obtain credit. After credit has been earned, please visit CPE monitor for your transcript. The Certificate of Achievement will be available online upon successful completion of the necessary activity requirements on the participant’s My Training page.\n\nRelease Date: March 31, 2023\n\nExpiration Date: March 31, 2026 - PLEASE NOTE: NO Home Study credit granted after this date; Live Credit can only be granted within 60 days from the day of the seminar attended."
    }
}